Basic Information

Email Address

• Email Address

  takeuchi.fumihiko.3rkyoto-u.ac.jp

Professional Memberships

• THE JAPANESE SOCIETY FOR VIROLOGY

Academic Degree

• 23 May 2019

  京都大学博士（生命科学）
• 25 Mar. 2015

  京都工芸繊維大学修士（工芸科学）

Academic Resume (Graduate Schools)

• 京都大学, 大学院生命科学研究科博士後期課程統合生命科学専攻, 研究指導認定退学
• 京都大学, 大学院生命科学研究科博士後期課程統合生命科学専攻, 修了
• 京都工芸繊維大学, 大学院工芸科学研究科応用生物学専攻修士課程, 修了

Academic Resume (Undergraduate School/Majors)

• 京都工芸繊維大学, 工芸科学部応用生物学科, 卒業

Research History

• From Jun. 2022, To Present

  京都大学医生物学研究所, 情報制御学分野, 特定助教
• From Apr. 2019, To May 2022

  Institute for Frontier Life and Medical Sciences, Kyoto University, Laboratory of Molecular Genetics, Department of Virus Research, Postdocs

ID,URL

• J-Global ID

  202001001465455783

• External link

  https://www.infront.kyoto-u.ac.jp/

researchmap URL

• https://researchmap.jp/f-takeuchi

Research

Research Areas

• Life sciences, Molecular biology, DNA, RNA, protein analysis
• Life sciences, Laboratory animal science, KO Mouse
• Life sciences, Virology, HBV (Hepatitis B Virus)

Papers

• Double-Stranded RNA Induces Mortality in an MDA5-Mediated Type I Interferonopathy Model.

  Francine Lianne Emralino; Saya Satoh; Nobuhiro Sakai; Masamichi Takami; Fumihiko Takeuchi; Nan Yan; Frank Rutsch; Takashi Fujita; Hiroki Kato

  Journal of immunology (Baltimore, Md. : 1950), 01 Dec. 2022

  
• Screening for inhibitor of episomal DNA identified dicumarol as a HepatitisB virus inhibitor.

  Takeuchi F; Ikeda S; Tsukamoto Y; Iwasawa Y; Qihao C; Otakaki Y; Ouda R; Yao W-L; Narita R; Hijikata M; Watashi K; Wakita T; Takeuchi K; Chayama K; Kogure A; Kato H; Fujita T

  PLOS ONE, Feb. 2019, Peer-reviewed

  
• Rosmarinic acid is a novel inhibitor for hepatitis b virus replication targeting viral epsilon RNA-polymerase interaction

  Yuta Tsukamoto; Sotaro Ikeda; Koji Uwai; Riho Taguchi; Kazuaki Chayama; Takemasa Sakaguchi; Ryo Narita; Wan-Ling Yao; Fumihiko Takeuchi; Yukie Otakaki; Koichi Watashi; Takaji Wakita; Hiroki Kato; Takashi Fujita

  PLoS ONE, 01 May 2018, Peer-reviewed

  
• Establishment of a human hepatocellular cell line capable of maintaining long-term replication of hepatitis B virus

  Wan-Ling Yao; Sotaro Ikeda; Yuta Tsukamoto; Keiko Shindo; Yukie Otakaki; Mian Qin; Yoshikazu Iwasawa; Fumihiko Takeuchi; Yuki Kaname; Yu-Chi Chou; Chungming Chang; Koichi Watashi; Takaji Wakita; Takeshi Noda; Hiroki Kato; Takashi Fujita

  INTERNATIONAL IMMUNOLOGY, Mar. 2017, Peer-reviewed

  
• Cardenolide Aglycones Inhibit Tumor Necrosis Factor alpha-Induced Expression of Intercellular Adhesion Molecule-1 at the Translation Step by Blocking Na+/K+-ATPase

  Yuji Okina; Fumihiko Takeuchi; Tomonobu Yokomichi; Yohei Takada; Takao Kataoka

  BIOLOGICAL & PHARMACEUTICAL BULLETIN, Jan. 2015, Peer-reviewed

  

Awards

• 28 Jun. 2019

  International HBV Meeting Travel Grant Award

External funds: Kakenhi

• Development of hepatitis B virus therapeutic drug and elucidation of elimination mechanism in vivo.

  Grant-in-Aid for Early-Career Scientists

  Basic Section 53010:Gastroenterology-related

  Kyoto University

  竹内 文彦

  From 01 Apr. 2021, To 31 Mar. 2023, Granted

  HBV;cccDNA;In vivo;B型肝炎ウイルス;環状DNA

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K15996/
• 高病原性ブニヤウイルス感染症の治療法の開発

  Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))

  Medium-sized Section 49:Pathology, infection/immunology, and related fields

  National Institute of Infectious Diseases

  下島 昌幸

  From 09 Oct. 2018, To 31 Mar. 2023, Granted

  高病原性ブニヤウイルス;SFTSウイルス;受容体;mAb;中和;高病原性ウイルス;クリミア・コンゴ出血熱ウイルス;重症熱性血小板減少症候群;リフトバレー熱;新規治療法;抗体;組み換えウイルス;クリミア・コンゴ出血熱;ウイルス受容体;高病原性ブニヤウイルス感染症;治療

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-18KK0232/

Administration

Faculty management (title, position)

• From 01 Apr. 2023

  共同利用機器等委員会　委員
• From 01 Apr. 2023

  化学物質管理委員会　委員